Table 2 Toxicities of DEB-TACE group and cTACE group
Variables | DEB-TACE (n = 56) | cTACE (n = 33) | P value |
|---|---|---|---|
Clinical toxicity (grade 1–2) | |||
Abdominal pain (yes/no) | 38/18, 67.9% | 29/4, 87.9% | 0.034 |
Fever (yes/no) | 22/34, 39.3% | 21/12, 63.6% | 0.026 |
Nausea (yes/no) | 3/53, 5.4% | 6/27, 18.2% | 0.072 |
Diarrhea (yes/no) | 3/53, 5.4% | 4/29, 12.1% | 0.416 |
Clinical toxicity (grade 3–4) | |||
Hepatic failure (yes/no) | 2/54, 3.6% | 2/31, 6.1% | 0.625 |
Death (yes/no) | 0 | 0 | N/A |
GI bleeding (yes/no) | 1/55, 1.8% | 1/32, 3.0% | 1.000 |
Laboratory toxicity (grade 1–2) | |||
Elevated ALT (yes/no) | 12/44, 21.4% | 9/24, 27.3% | 0.531 |
Elevated AST (yes/no) | 5/51, 8.9% | 8/25, 24.2% | 0.064 |
Elevated ALP (yes/no) | 10/46, 17.9% | 6/27, 18.2% | 0.969 |
Hyperbilirubinemia (yes/no) | 17/39, 30.4% | 9/24, 27.3% | 0.757 |
Creatinine (yes/no) | 0 | 0 | N/A |
Laboratory toxicity (grade 3–4) | |||
Elevated ALT (yes/no) | 0 | 0 | N/A |
Elevated AST (yes/no) | 0 | 0 | N/A |
Elevated ALP (yes/no) | 0 | 0 | N/A |
Hyperbilirubinemia (yes/no) | 1/55, 1.8% | 3/30, 9.1% | 0.142 |
Creatinine (yes/no) | 0 | 0 | N/A |